scholarly journals Preoperative and long-term efficacy and safety of lanreotide autogel in patients with thyrotropin-secreting pituitary adenoma: a multicenter, single-arm, phase 3 study in Japan

2021 ◽  
Author(s):  
Akira Shimatsu ◽  
Akinobu Nakamura ◽  
Yutaka Takahashi ◽  
Shingo Fujio ◽  
Fumitoshi Satoh ◽  
...  
Keyword(s):  
Pituitary Adenoma ◽  
Efficacy And Safety ◽  
Phase 3 ◽  
Term Efficacy ◽  
Lanreotide Autogel

Long-term Efficacy and Safety of Brodalumab in Patients With Psoriasis Disease Duration <10 and ≥10 Years: Analysis of Two Phase 3 Studies

2019 ◽  
Vol 3 ◽  
pp. S25
Author(s):  
Benjamin Ehst ◽  
George Han ◽  
Scott Guenthner ◽  
Kimberly Eads ◽  
Abby Jacobson
Keyword(s):  
Disease Duration ◽  
Efficacy And Safety ◽  
Phase 3 ◽  
Two Phase ◽  
Term Efficacy

Abstract not available.

scholarly journals Long-Term Efficacy and Safety of Hizentra® in Patients with Primary Immunodeficiency in Japan, Europe, and the United States: a Review of 7 Phase 3 Trials

2018 ◽  
Vol 38 (8) ◽  
pp. 864-875 ◽  
Author(s):  
Stephen Jolles ◽  
Mikhail A. Rojavin ◽  
John-Philip Lawo ◽  
Robert Nelson ◽  
Richard L. Wasserman ◽  
...  
Keyword(s):  
United States ◽  
Primary Immunodeficiency ◽  
The United States ◽  
Efficacy And Safety ◽  
Phase 3 ◽  
Term Efficacy

scholarly journals Long-term efficacy and safety of secukinumab in patients with psoriatic arthritis: 5-year (end-of-study) results from the phase 3 FUTURE 2 study

2020 ◽  
Vol 2 (4) ◽  
pp. e227-e235 ◽  
Author(s):  
Iain B McInnes ◽  
Philip J Mease ◽  
Alan J Kivitz ◽  
Peter Nash ◽  
Proton Rahman ◽  
...  
Keyword(s):  
Psoriatic Arthritis ◽  
Efficacy And Safety ◽  
Phase 3 ◽  
Term Efficacy ◽  
Study Results ◽  
Future 2
Sign in / Sign up

Export Citation Format

Share Document